JUNSHI BIO (01877) shareholders Shanghai Skye and Shanghai Tan Zheng plan to reduce their holdings of no more than 7.3927 million shares of the company's stock.

JUNSHI BIO (01877) announced that Shanghai Tan Ying and Shanghai Tan Zheng are optimistic about the company's development. Due to the fund's term and liquidity arrangements, Shanghai Tan Ying and Shanghai Tan Zheng plan to reduce their total holdings of the company's shares by no more than 739.27 million shares, with a total reduction ratio of not more than 0.75% of the company's total share capital, through centralized bidding and block trades. The reductions will be carried out as follows: (1) For reductions through centralized bidding, the total number of shares to be reduced over any consecutive 90-day period shall not exceed 0.75% of the company's total share capital, to be carried out within three months after 15 trading days from the disclosure of this announcement. (2) For reductions through block trades, the total number of shares to be reduced over any consecutive 90-day period shall not exceed 0.75% of the company's total share capital, to be carried out within three months after 15 trading days from the disclosure of this announcement. The reduction prices of the shares will be determined by the market price. During the period of the reduction plan, if the company undergoes events such as dividends, bonus issues, capital reserve fund increases in share capital, or rights issues, the number of shares to be reduced will be adjusted accordingly.